Pandemic Influenza Plan - Questar III

More documents

Recommendations

Info

Section 13: Public Health Preparedness Informatics counsel and BHNSM have the lead in developing data sharing agreements to address control over rules of data access, data protection, secondary disclosure and assurance multi-lateral data provision. A multi-program workgroup inclusive of epidemiology, Wadsworth Center, public health preparedness, hospital program and house counsel developed the data sharing documents for DOH executive and NYSACHO/LHD review/approval. ‣ Action items: o Implement agreements statewide. 7. Real Time Situational Awareness and Decision Suooprt Real-time data feeds from core PHP commerce systems will be summarized, linked, visualized and made available to executive decision makers, local health officials, health facility incident command and other key response partners through the executive dashboard on the Commerce system. Processes will build on the model used to instantiate and populate the dashboard deployment used in support of the RNC and include decision support. Rich internet architecture, SAS processing and HERDS GIS systems provide the underlying integration and visualization infrastructure for the dashboard. Data feeds will be linked to the dashboard from existing commerce systems described in Parts I.D.4 and I.D.5 inclusive of: • Event detection and surveillance systems: ED reporting, syndromic surveillance systems, HERDS surveillance at health facilities, NORA and ECLRS • Case reporting, contact tracking and isolation: CDESS and HERDS functions supporting isolation and quarantine. • Outbreak tracking as implemented in HERDS. • HERDS health facility reporting: attributes, personnel, equipment, supplies, assets, pharmaceutical, vaccine and antivirals, surge, resource needs and availability • Volunteer rosters. • Communications Directory. • HERDS SNS/MERC reporting/tracking. • Counter Measure Response Administration. • Avian and mammal surveillance. Decision support and visualization made available through the dashboard include • Time series monitoring of event detection information, surveillance, outbreak and case reporting. • Outbreak tracking of geographic and demographic extent of event. • Static, time series and spatial display of medical personnel resources, facility resources, vaccine inventory and needs, counter measure administration (as described in Part I). • Resource materials. Functionality provided through the dashboard include • Health alerting • Secure collaboration February 7, 2006 13-22
Section 13: Public Health Preparedness Informatics • Webinar access • Cross jurisdictional communications directory contact lookup B. Surveillance 1. Routine surveillance and Event detection • Community-Acquired Influenza. All hospitals in NY state report weekly through HERDS on patients (and associated age demographics) admitted with laboratory-confirmed influenza (Type A, B, or Unspecified). This information is available on commerce as live data feeds to local health, state and regional offices as soon as it is reported by Facilities. HERDS GIS system provides a spatial visualization of these live data feeds. ECLRS clinical lab test results for influenza are also monitored and tracked. ‣ Action items: o Extend HERDS instances to primary care clinics, home health agencies and adult care facilities to enable routine influenza surveillance at these facility types. • Facility-Acquired (Nosocomial) Influenza and ILI Outbreaks. Nosocomialacquired infection outbreaks (including Influenza ILI) are reported on a routine basis by hospitals and long-term care. The data is available in real time via the NORA system on commerce to LHDs, state and regional offices. • Syndromic Surveillance. Time series and trends in OTC (RODS data) medications and Medicaid prescription data is monitored statewide on an ongoing basis. • Practitioner Surveillance. The BNE practitioner recruitment process for BNE and medical volunteers can be leveraged to include recruitment of volunteer sentinel physician ILI reporting through the commerce system. • Avian and Animal Surveillance. The statewide arbovirus reporting system reporting system supports ad hoc reporting of symptoms and deaths of mammals and birds. This system can be adapted for reporting of influenza symptoms/events within these populations. As veterinarians and their offices are being brought onto commerce as part of the BNE prescription pad registration rollout, they will be part of the commerce system and available to report to the NYSDOH reporting system. The NYS Department of Agriculture and Markets operates a separate site for veterinary reporting, the New York State Animal Incident Notification and Tracking System (NYSAINTS). • The NYS Department of Agriculture and Markets (NYSDAM) operates its own site for veterinary reporting, the New York State Animal Incident Notification and Tracking System (NYSAINTS) and has been designated as the point of collection for data regarding symptoms and death in mammal and wild bird populations, as well as for poultry flocks. A process for automatically transferring summary data from NYSAINTS to NYSDOH Commerce data visualization tools for posting on the executive dashboard will enable decisions of where intense epidemiological human case surveillance may need to be focused and provide data for analyzing the relationship February 7, 2006 13-23
Page 1 and 2:
February206 Pandemic Plan NewYorkSt
Page 3 and 4:
Introduction Pandemic influenza occ
Page 5 and 6:
example, at this time, it is realis
Page 7 and 8:
Acronyms (cont.) IND IHANS IRB ISHS
Page 9 and 10:
Section 1: Command and Control I. O
Page 11 and 12:
Section 1: Command and Control pers
Page 13 and 14:
February 7, 2006 Appendix 1-A
Page 15 and 16:
Appendix 1-B The Public Health Law
Page 17 and 18:
Appendix 1-B communicable diseases
Page 19 and 20:
Appendix 1-C Management Office or t
Page 21 and 22:
Appendix 1-E Suspension of Public M
Page 23 and 24:
Appendix 1-G A Guide to New York St
Page 25 and 26:
Appendix 1-G health commissioner. P
Page 27 and 28:
Appendix 1-G 8. State Institutions
Page 29 and 30:
Appendix 1-G b. Governor May Invoke
Page 31 and 32:
Appendix 1-G may direct, pursuant t
Page 33 and 34:
Appendix 1-G c. Commissioner of Gen
Page 35 and 36:
Appendix 1-G Designation of emergen
Page 37 and 38:
Appendix 1-G physician’s assistan
Page 39 and 40:
Appendix 1-H Summary of Public Offi
Page 41 and 42:
Section 2: Surveillance and Laborat
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Appendix 2-A • Surveillance Crite
Page 65 and 66:
Appendix 2-A • In New York City,
Page 67 and 68:
NYSDOH Novel Influenza Case Report
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Appendix 2-C to health care provide
Page 75 and 76:
Virus Detection History NYS Lab Num
Page 77 and 78:
Section 3: Healthcare Planning and
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Section 4: Infection Control I. Ove
Page 127 and 128:
Section 4: Infection Control I. Ove
Page 129 and 130:
Section 4: Infection Control A. Bas
Page 131 and 132:
Section 4: Infection Control Drople
Page 133 and 134:
Section 4: Infection Control • Pe
Page 135 and 136:
Section 4: Infection Control o Noti
Page 137 and 138:
Section 4: Infection Control E. Coh
Page 139 and 140:
Section 4: Infection Control If wid
Page 141 and 142:
Section 4: Infection Control • En
Page 143 and 144:
Section 4: Infection Control should
Page 145 and 146:
Section 4: Infection Control Policy
Page 147 and 148:
Section 4: Infection Control o Staf
Page 149 and 150:
Section 4: Infection Control • De
Page 151 and 152:
Section 4: Infection Control • Pr
Page 153 and 154:
Section 4: Infection Control The ma
Page 155 and 156:
Section 4: Infection Control • Up
Page 157 and 158:
Section 4: Infection Control Health
Page 159 and 160:
Appendix 4-A Soiled linen and laund
Page 161 and 162:
Appendix 4-B Respiratory Hygiene/Co
Page 163 and 164:
Section 5: Clinical Guidelines I. O
Page 165 and 166:
Section 5: Clinical Guidelines incu
Page 167 and 168:
Section 5: Clinical Guidelines 1) N
Page 169 and 170:
Section 5: Clinical Guidelines infe
Page 171 and 172:
Section 5: Clinical Guidelines Alth
Page 173 and 174:
Section 5: Clinical Guidelines Infe
Page 175 and 176:
Section 5: Clinical Guidelines •
Page 177 and 178:
Appendix 5-B Clinical Evaluation of
Page 179 and 180:
Appendix 5-C Special Situations and
Page 181 and 182:
Appendix 5-D handling soiled laundr
Page 183 and 184:
DRAFT Appendix 5-E Footnotes to App
Page 185 and 186:
Appendix 5-F February 7, 2006 1
Page 187 and 188:
Appendix 5-F 7. Guidance on the eva
Page 189 and 190:
Appendix 5-H Source: U.S. Departmen
Page 191 and 192:
February 7, 2006 2 Appendix 5-I
Page 193 and 194:
Appendix 5-J Clinical Presentation
Page 195 and 196:
Appendix 5-J diabetes mellitus), re
Page 197 and 198:
Appendix 5-J resistant S. aureus (M
Page 199 and 200:
Appendix 5-K eight patients—all o
Page 201 and 202:
Appendix 5-L Guidelines for Managem
Page 203 and 204:
Appendix 5-L testing should be perf
Page 205 and 206:
Appendix 5-L February 7, 2006 5
Page 207 and 208:
Section 6: Vaccine Procurement, Dis
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Appendix 6-A Vaccine Priority Group
Page 221 and 222:
Appendix 6-B Mass Clinic Planning O
Page 223 and 224:
Appendix 6-C Vaccine and Antiviral
Page 225 and 226:
Appendix 6-C 1. Request Phase The r
Page 227 and 228:
Appendix 6-C 3. Receipt and Sign-of
Page 229 and 230:
Appendix 6-C • Work with local he
Page 231 and 232:
Section 7: Antiviral Medication Pro
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Appendix 7-A Characteristics of Ant
Page 251 and 252:
Appendix 7-B a The drug package ins
Page 253 and 254:
Appendix 7-C 7 HCWs in emergency de
Page 255 and 256:
Section 8: Travel-Related Disease C
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Appendix 8-A Home or Community-Base
Page 269 and 270:
Appendix 8-B Contact Identification
Page 271 and 272:
Appendix 8-B • Determine the time
Page 273 and 274:
Appendix 8-C Administrative Data: S
Page 275 and 276:
Appendix 8-D CONTACT DAILY TEMPERAT
Page 277 and 278:
Appendix 8-F Definitions: Intervent
Page 279 and 280:
Appendix 8-F facility. No specific
Page 281 and 282:
Appendix 8-F • Resources Required
Page 283 and 284:
Appendix 8-G Business Pandemic Infl
Page 285 and 286:
Appendix 8-G 4. Allocate resources
Page 287 and 288:
Appendix 8-H CDC guidelines suggest
Page 289 and 290:
Appendix 8-H If I am not masked I
Page 291 and 292:
Appendix 8-H NYSDOH Model Influenza
Page 293 and 294:
Appendix 8-H I understand that if
Page 295 and 296:
Section 9: Communications I. Overvi
Page 297 and 298:
Section 9: Communications and commu
Page 299 and 300:
Section 9: Communications web pages
Page 301 and 302:
Section 9: Communications Local Hea
Page 303 and 304:
Section 9: Communications • A JIC
Page 305 and 306:
Section 9: Communications backup to
Page 307 and 308:
Section 9: Communications • In th
Page 309 and 310:
Appendix 9-A Public Health Risk Com
Page 311 and 312:
Appendix 9-C New York State Departm
Page 313 and 314:
Appendix 9-C PRE-EVENT MESSAGE MAP:
Page 315 and 316:
Appendix 9-C PROTECTIVE MESSAGE MAP
Page 317 and 318:
Appendix 9-C TREATMENT MESSAGE MAP:
Page 319 and 320:
Appendix 9-C BUSINESS CONTINUITY PR
Page 321 and 322:
Section 10: Training and Education
Page 323 and 324:
Section 10: Training and Education
Page 325 and 326: Section 10: Training and Education
Page 327 and 328: Appendix 10-A NYSDOH STAFF PRIVATE
Page 335 and 336: FACILITY- BASED RNs FACILITY- BASED
Page 341 and 342: Section 11: Workforce Support I. Ov
Page 343 and 344: Section 11: Workforce Support Pande
Page 345 and 346: Section 12: Highly Pathogenic H5N1
Page 347 and 348: Section 12: H5N1 in Non-Human Anima
Page 355 and 356: Section 13: Public Health Preparedn
Page 375: Section 13: Public Health Preparedn
Page 389 and 390: Appendix 13-A NYSDOH Roles Notified
Page 391 and 392: Appendix 13-B Notifications sent by
Page 393 and 394: Appendix 13-B HAN posting is used a
Page 395 and 396: Appendix 13-B notification system t
Page 397 and 398: Appendix 13-C Overview of the Healt
Page 399 and 400: Appendix 13-C • Ongoing surveilla
Page 401 and 402: Table 1. Summary of HERDS Use To da
Page 403 and 404: Appendix 13-D Commerce Access and A
Page 405 and 406: Appendix 13-D Table 3. Organization
show all

Pandemic Influenza Plan - Questar III

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?